Monday, Aug 7: 2:05 PM - 2:25 PM
Topic-Contributed Paper Session
Metro Toronto Convention Centre
Drug safety data present many challenges with regard to curation, analysis, interpretation, and reporting. Visual analytics presents an alternative to the traditional tabular outputs for exploring, assessing, and reporting safety data and presents an opportunity to enhance and facilitate the evaluation of drug safety and help convey multiple pieces of information concisely and more effectively than tables. Graphical depictions of safety data can help facilitate better communication of drug safety findings by blending data visualization, statistical, and data mining techniques to create visualization modalities that help users make sense of safety data with an emphasis on how to complement computation and visualization to perform effective and meaningful analyses. Developing readily available tools for visual analytics of drug safety data that take into account considerations revolving around structured assessment driven by safety questions of interest is desirable along with considerations for user interface parlor. This discussion will highlight a tool from a joint collaboration of the ASA, PHUSE, and FDA.